Dave Johnson Founder of Solve Therapeutics Backed byGeneral AtlanticChuck Feeney LinkedIn SourcesSolve Therapeutics Raises 20 Million to Develop Best-in-Class ADCs for Solid Tumors — 2025-11 Browse all founders · Browse investors